You are leaving Medscape Education
Cancel Continue
News & Perspective
Drugs & Diseases
CME & Education
Video
Decision Point

Specialty: Multispecialty
Allergy & Immunology
Anesthesiology
Business of Medicine
Cardiology
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Medicine
Gastroenterology
General Surgery
Hematology - Oncology
HIV/AIDS
Hospital Medicine
Infectious Diseases
Internal Medicine
Multispecialty
Nephrology
Neurology
Ob/Gyn & Women's Health
Oncology
Ophthalmology
Orthopedics
Pathology & Lab Medicine
Pediatrics
Plastic Surgery
Psychiatry
Public Health
Pulmonary Medicine
Radiology
Rheumatology
Transplantation
Urology
Interprofessional
Shared Decision Making
Nurses
Pharmacists
Edition: English

Medscape

English
Deutsch
Español
Français
Português
UKNew

Univadis

Sign Up It's Free!
English Edition

Medscape

Univadis

    X
    Univadis from Medscape

    No Results

      Saturday, November 23, 2024
      News & Perspective Drugs & Diseases CME & Education Video Decision Point
      Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
      CME & Education > Search
      CME & Education
      Multispecialty
      Activity Tracker
      Loading Credits...
      Log In to Track Your Progress.
      View Tracker
      View Tracker
      Your Activities
      Specialties
      STOP AND THINK...
      Could it be a rare disease?
      Latest In Multispecialty
      Filter
      All U.S. Non-U.S.
      Topics
      Credits
      Format
      Type

      Select all that apply

      Topics

        Credits

          Format

            Type
              Parkinson Disease 907 global 1 0.75 1 Neurology & Neurosurgery CME 0.75 Roundtable 0 1
              The Impact of Pharmacokinetics on Therapeutic Outcomes in Parkinson Disease
              What are the clinical benefits of continuous dopaminergic administration for patients with Parkinson disease (PD)? Start activity
              The Impact of Pharmacokinetics on Therapeutic Outcomes in Parkinson Disease
              View Details
              0.75Credits 45 MIN
              Continuous Glucose Monitoring 6016449 global 1 0.50 1 2 0.50 5 9 0.50 1047 Family Medicine/Primary Care CME / ABIM MOC / CE 0.5 Roundtable 0 1
              Patient Journeys in CGM
              Have you ever wondered how technology could improve the lives of patients who have type 2 diabetes? Join us as we explore the impact of continuous glucose monitoring (CGM) from real patient experiences. Start activity
              Patient Journeys in CGM
              View Details
              0.5Credits 30 MIN
              Food Allergy 65081 global 1 0.50 1 9 0.50 1047 Allergy & Clinical Immunology CME / ABIM MOC 0.5 Roundtable 0 1
              Agnostic Avenues in Food Allergy: Innovations in the Treatment Landscape
              Join the experts as they delve into the latest innovations and strategies in the treatment landscape of food allergies. Start activity
              Agnostic Avenues in Food Allergy: Innovations in the Treatment Landscape
              View Details
              0.5Credits 30 MIN
              0 global 1 1.00 1 2 1.00 5 3 1.00 15 9 1.00 1047 Hematology-Oncology CME / ABIM MOC / CE 1.0 Clinical Review 0 1
              Expanding Immunotherapy Options in Colorectal Cancer
              Learn how clinical trial data are reshaping neoadjuvant care for patients with deficient mismatch repair (dMMR) colorectal cancer (CRC). Start activity
              Expanding Immunotherapy Options in Colorectal Cancer
              View Details
              1.0Credits 60 MIN
              Multiple Sclerosis 918 global 1 0.50 1 2 0.50 5 9 0.50 1047 Neurology & Neurosurgery CME / ABIM MOC / CE 0.5 Commentary 0 1
              Improving the Timely and Equitable Diagnosis of Multiple Sclerosis
              How the 2024 updates to the McDonald criteria will improve the accuracy of multiple sclerosis (MS) diagnosis. Start activity
              Improving the Timely and Equitable Diagnosis of Multiple Sclerosis
              View Details
              0.5Credits 30 MIN
              Non-Alcoholic Fatty Liver Disease 5000208 global 1 0.50 1 2 0.50 5 9 0.50 1047 Gastroenterology CME / ABIM MOC / CE 0.5 Clinical Case 0 1
              Steatotic Liver Disease: What Does It Mean for Your Patients?
              Delve into the nuances of metabolic dysfunction-associated steatohepatitis (MASH) with expert insights on metabolic risk factors, risk stratification, and cutting-edge treatments. Start activity
              Steatotic Liver Disease: What Does It Mean for Your Patients?
              View Details
              0.5Credits 30 MIN
              View All
              Curated Collections
              Curated activities and resources from our partners and committee
              View All
              You Might Like
              Because you completed the activity:
              Upcoming Events
              View All
              Simulation
              View All
              Specialties
               
              Find Us On
              About
              About Medscape Privacy Policy Editorial Policy Cookies Manage Preferences Terms of Use Advertising Policy Help Center
              Membership
              Become a Member About You Professional Information Newsletters & Alerts Market Research
              App
              Medscape
              Editions
              English Deutsch Español Français Português
              All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC. This website also contains material copyrighted by 3rd parties.